Cited by 59Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsPrion Diseases and Protein Misfolding

Tau misfolding efficiently propagates between individual intact hippocampal neurons

Open access
Hallinan, Grace I., Vargas-Caballero, Mariana, West, Jonathan, Deinhardt, Katrin·2019·The Journal of Neuroscience

Published version of a preprint

Abstract

Neurofibrillary tangles, formed of misfolded, hyperphosphorylated tau protein, are a pathological hallmark of several neurodegenerations, including Alzheimer's disease. Tau pathology spreads between neurons and propagates misfolding in a prion-like manner throughout connected neuronal circuits. Tauopathy is accompanied by significant neuronal death, but the relationships between initial tau misfolding, propagation across connected neurons and cytotoxicity remain unclear. In particular the immediate functional consequence of tau misfolding for the individual neuron is not well understood. Here, using microfluidic devices to recreate discretely organized neuronal connections, we show that the spread and propagation of misfolded tau between individual murine neurons is rapid and efficient; it occurs within days. The neurons containing and propagating tau pathology display selective axonal transport deficits but remain viable and electrically competent. Therefore, we demonstrate that seed-competent misfolded tau species do not acutely cause cell death, but instead initiate discrete cellular dysfunctions. SIGNIFICANCE STATEMENT Public awareness of progressive neurodegenerations such as dementias associated with aging or repetitive head trauma is rising. Protein misfolding underlies many neurodegenerative diseases including tauopathies, where the misfolded tau protein propagates pathology through connected brain circuits in a prion-like manner. Clinically, these diseases progress over the course of years. Here we show that the underlying protein misfolding propagates rapidly between individual neurons. Presence of misfolded tau is not directly cytotoxic to the neuron; the cells remain viable with limited deficits. This suggests that neurons with tau pathology could be rescued with a therapeutic disease modifier and highlights an under-appreciated time window for such therapeutic intervention.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.1590-19.2019

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Hallinan et al., 2019 reported lysosome transport defects with E14 tau opposite to those observed here, but their study used more mature hippocampal neurons and observed MC1-positive tau aggregates in axons.

    “Hallinan et al., 2019 reported lysosome transport defects with E14 tau opposite to those observed here, but their study used more mature hippocampal neurons and observed MC1-positive tau aggregates in axons”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Authors
Hallinan, G. I., Vargas-Caballero, M., West, J., & Deinhardt, K.
Affiliations
University of Southampton (GB)
Venue
The Journal of Neuroscience
Published
2019-10-28
Volume
39
Issue
48
Pages
9623-9632
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2982293381
Cited by
59
References
13
Citations by year
2026: 4 · 2025: 7 · 2024: 9 · 2023: 9 · 2022: 1 · 2021: 13 · 2020: 15 · 2019: 1
FWCI
5.03
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • ePrints Soton (University of Southampton) (acceptedVersion)
Funders
  • Directorate for Biological Sciences
  • Biotechnology and Biological Sciences Research Council (BB/L007576/1)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
Keywords
tau misfolding, tauopathy, prion-like propagation, neurofibrillary tangles, Alzheimer's disease, hippocampal neurons, neuronal viability, disease-modifying therapy, neurodegeneration
MeSH terms
Animals, Cells, Cultured, Hippocampus, Humans, Mice, Inbred C57BL, Neurons, tau Proteins, Protein Folding, Mice, Proteostasis Deficiencies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review